Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03504956 · ClinicalTrials.gov registry record · NA
Coronary Atherosclerosis T1-Weighted Characterization (CATCH)
A NA study of Coronary Atherosclerosis, sponsored by Cedars-Sinai Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT03504956 is a NA study of Coronary Atherosclerosis that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 150 participants, below the 329-participant average among 5 other Coronary Atherosclerosis trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03504956, a NA study of Coronary Atherosclerosis, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study proposes to develop an MRI technique named Coronary Atherosclerosis T1-weighed Characterization (CATCH) that will improve the quality and reliability of coronary atherosclerosis evaluation, as well as simplify the scanning process and significantly shorten imaging time compared with conventional imaging methods.
Conditions Studied
Interventions
- DEVICE Cardiac MRI
- DRUG Contrast
- DRUG Beta blocker
Study Locations (1)
California
- Cedars-Sinai Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2018-07-30 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03504956
The ClinicalTrials.gov registry entry for NCT03504956 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 329-participant average among 5 other Coronary Atherosclerosis trials with a reported enrollment target (54% lower). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Atherosclerosis appearing as the primary indexed condition, and to 3 interventions - of which Cardiac MRI is the first listed.
NCT03504956 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03504956 about?
NCT03504956 is a clinical study titled "Coronary Atherosclerosis T1-Weighted Characterization (CATCH)". This study proposes to develop an MRI technique named Coronary Atherosclerosis T1-weighed Characterization (CATCH) that will improve the quality and reliability of coronary atherosclerosis evaluation, as well as simplify the scanning process and significantly shorten imaging time compared with conve...
What is the current status of trial NCT03504956?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2018-07-30. Estimated completion is 2026-12-31.
What conditions does trial NCT03504956 study?
This clinical trial studies the following conditions: Coronary Atherosclerosis.
What interventions are being tested in trial NCT03504956?
The interventions under investigation include: Cardiac MRI (DEVICE), Contrast (DRUG), Beta blocker (DRUG).
Who is sponsoring clinical trial NCT03504956?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03504956 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Atherosclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI)
COMPLETED · NA
-
Using CTA Measures to Define Cardiac Risk In NFL Alumni
RECRUITING
-
Firefighter Aged Garlic Extract Investigation With CoQ10 as a Treatment for Heart Disease (FAITH)
COMPLETED · Phase 3
-
Subclinical Atherosclerosis in HIV-infected Patients
COMPLETED
-
STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.